Virax Biolabs is a global biotechnology company specializing in testing technologies to detect immune responses and diagnose viral diseases. With three distinct platforms, ViraxImmune™, ViraxClear™, and ViraxVet™, they offer a range of products and services to address various healthcare needs. Their primary focus lies in T-Cell testing, a cutting-edge method that has shown significant effectiveness in diagnosing and developing therapeutics for COVID-19, as well as other threats like Hepatitis B, Malaria, and Human Papilloma Virus.

By harnessing the potential of T-Cell testing, Virax Biolabs aims to revolutionize immunology with a potentially game-changing platform. In addition to T-Cell testing, they also specialize in in vitro diagnostics, providing distribution solutions for animal health. With a commitment to advancing healthcare, Virax Biolabs actively shares resources, engages with investors, and maintains an informative blog and media room.

They also host events and offer exciting career opportunities. Partner with Virax Biolabs to access their innovative testing technologies and contribute to the global fight against viral diseases. Contact them today or sign up for their newsletter to stay updated on their latest products and company developments